Disease Control and Prevention Vaccine Market
- 2026 年市場規模
- USD 114.9 Bn
- 2033 年預估規模
- USD 255.4 Bn
- 年複合成長率 CAGR
- 12.4%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Disease Control and Prevention Vaccine Market, By Product Type (Live-attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines), By Type (Monovalent Vaccines, Multivalent Vaccines), By Route of Administration (Oral, Injectable), By Age Group (Pediatric Vaccines, Adult Vaccines), By Indication (Infectious Diseases, Cancer, Other Indications), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Vaccines are the biological preparation used for stimulating antibody production to activate immune system against diseases such as influenza, Hepatitis A, Hepatitis B, Human Papillomavirus, Polio, and Rabies. High prevalence of infectious disease and increasing governmental initiative for implementing nationalized vaccination programme are expected to drive growth of the vaccine market, whereas high developmental cost of vaccine is expected to hamper growth of the vaccine market. For instance, according to the Centers for Disease Control and Prevention (CDC), 2015, flu vaccinations prevented an around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.
Market Dynamics
The global disease control and prevention vaccine market is projected to witness significant growth over the forecast period, owing to rapid advancements in technology for development of novel vaccines such as recombinant and cell-based technologies, resulting in increasing production of the vaccines. For instance, in 2018, collaboration between Austrian biotech Themis Bioscience and Oslo-based Coalition for Epidemic Preparedness Innovations (CEIP). CEIP will fund US$ 37.5 million for vaccine development for five years. Moreover, governmental bodied supports the research and development program leading to the development of improved form of presently available vaccines. For instance, in 2015, a National Institute of Allergy and Infectious Disease scientists engineered a protein to maintain the specific shape of the viral spike, stimulating the immune system to produce powerful anti-HIV antibodies. However, manufacturing cost as well as large gap between demand and supply leading to hike in pricing is expected to hinder the growth of disease control and prevention vaccination market.
Key features of the study
• This report provides in-depth analysis of the disease control and prevention vaccine market and its Type, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2026 – 2033, considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global disease control and prevention vaccine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
• Key companies covered as a part of this study include GlaxoSmithKline plc (GSK), Merck & Co. Inc., Sanofi, AstraZeneca PLC, Pfizer, Inc., Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., Astellas Pharma Inc., and Daiichi Sankyo
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.
• The global disease control and prevention vaccine market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for disease control and prevention vaccine market, research and consulting firms, new entrants and financial analysts.
Market Segmentation
• By Product Type (Revenue, USD Bn, 2021-2033)
o Live-attenuated Vaccines
o Inactivated Vaccines
o Recombinant Vaccines
o Toxoid Vaccines
• By Type (Revenue, USD Bn, 2021-2033)
o Monovalent Vaccines
o Multivalent Vaccines
• By Route of Administration (Revenue, USD Bn, 2021-2033)
o Oral
o Injectable
• By Age Group (Revenue, USD Bn, 2021-2033)
o Pediatric Vaccines
o Adult Vaccines
• By Indication (Revenue, USD Bn, 2021-2033)
o Infectious Diseases
o Cancer
o Other Indications
• By Region (Revenue, USD Bn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Company Profiles
o Pfizer Inc.
o GlaxoSmithKline plc
o Sanofi Pasteur
o Merck & Co., Inc.
o AstraZeneca PLC
o Johnson & Johnson
o Moderna, Inc.
o BioNTech SE
o Novavax, Inc.
o Sinovac Biotech Ltd.
o Serum Institute of India Pvt. Ltd.
o Bharat Biotech International Ltd.
o CSL Limited
o Dynavax Technologies Corporation
o Valneva SE Inovio Pharmaceuticals, Inc.
o Vaxart, Inc.
o Astellas Pharma Inc.
o Daiichi Sankyo Company
o Limited and Panacea Biotec Ltd.
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Product Type
Market Snippet, By Type
Market Snippet, By Route of Administration
Market Snippet, By Age Group
Market Snippet, By Indication
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Governmental Initiative
o Product Pipeline
o Regulatory Landscape
o PEST Analysis
o PORTER’S Five Forces
4. Global Disease Control and Prevention Vaccines Market, By Product Type, 2021–2033, (US$ Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Live-attenuated Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
o Inactivated Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
o Recombinant Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
o Toxoid Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
5. Global Disease Control and Prevention Vaccines Market, By Type, 2021–2033, (US$ Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Monovalent Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
o Multivalent Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
6. Global Disease Control and Prevention Vaccines Market, By Route of Administration, 2021–2033, (US$ Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
o Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
7. Global Disease Control and Prevention Vaccines Market, By Age Group, 2021–2033, (US$ Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Pediatric Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
o Adult Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
8. Global Disease Control and Prevention Vaccines Market, By Indication, 2021–2033, (US$ Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Infectious Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
o Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
o Other Indications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
9. Global Disease Control and Prevention Vaccines Market, By Regions, 2021–2033, (US$ Billion)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, By Region, 2022–2033
Regional Trends
o North America
U.S.
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
Canada
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
o Europe
U.K.
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
Germany
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
Italy
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
France
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
Spain
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
Russia
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
Rest of Europe
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
o Asia Pacific
China
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
Japan
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
India
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
ASEAN
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
Australia
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
South Korea
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
Rest of Asia Pacific
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
o Latin America
Brazil
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
Mexico
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
Rest of Latin America
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
o Africa
North Africa
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
Central Africa
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
South Africa
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
o Middle East
GCC Countries
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
Israel
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
Rest of Middle East
o Market Size and Forecast, By Product Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Type, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Route of Administration, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Age Group, 2021–2033, (US$ Billion)
o Market Size and Forecast, By Indication, 2021–2033, (US$ Billion)
10. Competitive Landscape
o Heat Map Analysis
o Company Profiles
Pfizer Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
GlaxoSmithKline plc
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Sanofi Pasteur
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Merck & Co., Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
AstraZeneca PLC
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Johnson & Johnson
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Moderna, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
BioNTech SE
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Novavax, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Sinovac Biotech Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Serum Institute of India Pvt. Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Bharat Biotech International Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
CSL Limited
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Dynavax Technologies Corporation
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Valneva SE Inovio Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Astellas Pharma Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Daiichi Sankyo Company, Limited
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Panacea Biotec Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Analyst Views
11. Section
o References
o Research Methodology
o About Us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們